Want to join the conversation?
$RRC said that 1Q16-ending debt EBITDAX ratio was 3.3 times. On the cost side of the ledger, cash unit costs were down $0.01 for last year in total unit cost, including DD&A which was down $0.29 from last year. All cost categories came in below the guidance with direct cash operating cost at $0.19 per Mcfe.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?